Peptides DB
Research-centric peptide and protocol reference hub
Study 22 of 23LL-37 literatureJournal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · Observational2026

Vaginitis testing outcomes by documented symptom status in a student-run free clinic: a retrospective study.

Documented symptom status did not consistently match test results for vaginitis in this clinic population, indicating potential issues with symptom-based diagnosis.

Read at Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and GynaecologyAdd to compare

Where it sits

this study against the rest of the ll-37 corpus
5
Preclinical
12
Observational · this one
0
Open-label
3
Randomised
3
Reviews

Summary and findings

This study assessed vaginitis testing outcomes in a student-run free clinic, focusing on patients with and without documented symptoms. A total of 104 testing encounters were reviewed for bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), or trichomoniasis vaginalis (TV). No significant differences were found in test results based on symptom status.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.n=1042026

Abstract

The authors’ words, as Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology supplied them

<h4>Background</h4>Vaginitis is a common gynaecologic condition in patients assigned female at birth in the United States, most often caused by bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), or trichomoniasis vaginalis (TV). Symptoms such as discharge, irritation, and burning often overlap. Symptom-based diagnosis is frequently inaccurate, with correct identification in only about half of cases. Empiric treatment without confirmatory testing remains common and can drive inappropriate therapy and antimicrobial resistance. Uninsured populations face higher infection burdens and barriers to care, yet data on vaginitis testing outcomes in student-run free clinics (SRFCs) are limited.<h4>Methods</h4>We conducted an IRB-approved retrospective chart review of patients receiving vaginitis testing at a no-cost SRFC affiliated with a Midwestern academic medical centre between October 2019 and November 2023. 104 testing encounters met inclusion criteria for BV, VVC, or TV testing. Demographics, age, and symptom status were extracted from the electronic medical record. Encounters were categorised as having documented vaginitis symptoms or no documented symptoms at the time of testing. All tests used transcription-mediated amplification. Proportional-difference chi-square tests compared results by symptom status, and logistic regression assessed associations between age and positive test results.<h4>Results</h4>The sample was predominantly comprised of patients assigned female at birth with a mean age of 31.1 years; 38% identified as Black. No significant differences were observed in positive or negative BV, VVC, or TV test results between encounters with and without documented vaginitis symptoms. Comparisons of positive VVC and TV results were limited by the small number of positive cases. Age was not associated with testing positive for BV, VVC, or TV.<h4>Conclusions</h4>Documented symptom status did not consistently correspond with organism-specific test results in this uninsured clinic population. Findings among patients without documented symptoms should be interpreted cautiously because testing was frequently bundled and symptom status was determined retrospectively.

Background

This paper addresses the accuracy of symptom-based diagnosis of vaginitis, a common condition among patients assigned female at birth in the U.S. Previous studies indicate that symptom-based diagnoses can be inaccurate, with correct identification in only about half of cases. The study is significant as it explores vaginitis testing outcomes in uninsured populations, where data is limited.

Methods

The study employed a retrospective chart review design, analyzing 104 testing encounters for BV, VVC, or TV at a student-run free clinic from October 2019 to November 2023. The population consisted predominantly of patients assigned female at birth, with demographics and symptom status extracted from electronic medical records. Proportional-difference chi-square tests and logistic regression were used to analyze the data.

Results

The analysis revealed no significant differences in positive or negative test results for BV, VVC, or TV based on documented symptom status. Comparisons of positive results for VVC and TV were limited due to a small number of positive cases. Age was not found to be associated with positive test results for any of the conditions.

Interpretation

The findings suggest that documented symptom status does not reliably predict organism-specific test results in this population. This aligns with previous literature indicating that symptom-based diagnoses can be misleading. However, the small sample size and retrospective design limit the conclusions that can be drawn, particularly regarding the clinical implications of these results.

Key findings

  • Mean age of patients was 31.1 years.
  • 38% of patients identified as Black.
  • No significant differences in positive or negative BV, VVC, or TV test results between encounters with and without documented symptoms.

Limitations

  • Retrospective study design.
  • Small sample size of 104 encounters.
  • Symptom status determined retrospectively.
  • Testing frequently bundled, complicating interpretation.

Elsewhere in the LL-37 corpus

AHigh-dose inhaled nitric oxide for severe pneumonia caused by multidrug-resistant bacteria: a randomized controlled trial protocol.Annals of medicine · 2026 · Not reported in abstract.HumanDGlobal trends and molecular epidemiology of Azithromycin-resistant &lt;i&gt;Salmonella&lt;/i&gt;: A systematic review and meta-analysis.One health (Amsterdam, Netherlands) · 2026 · n=15514 · Pooled prevalence of azithromycin resistance among Salmonella isolates was 9.12% (95% CI: 6.53-12.07).reviewDCross-species genomic analysis of &lt;i&gt;Salmonella enterica&lt;/i&gt; subspecies &lt;i&gt;enterica&lt;/i&gt; serovar Dublin isolated from dairy cattle, dogs, and humans in Florida from 2019 to 2024.One health (Amsterdam, Netherlands) · 2026 · n=78 · Not reported in abstract.BB-lineage cells interact with antimicrobial peptides in the gingival tissue of stage 4 periodontitis.biorxiv-preprint · 2026 · Not reported in abstract.HumanBAsthma diagnosis in school-age children: a survey among Swiss physiciansbiorxiv-preprint · 2026 · 50% of PCPs reported no access to spirometry, 95% reported no access to FeNO.HumanBLatent profiles of eating disorder symptoms among transgender, gender diverse, and cisgender people with lived experience of eating disorders: associations with neurodivergent traits and gender dysphoriabiorxiv-preprint · 2026 · Binge eating with ED cognitions at 29.4% of the sample.Human